472 related articles for article (PubMed ID: 34484246)
1. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.
Vella G; Guelfi S; Bergers G
Front Immunol; 2021; 12():736670. PubMed ID: 34484246
[TBL] [Abstract][Full Text] [Related]
2. Defining High Endothelial Venules and Tertiary Lymphoid Structures in Cancer.
Jones E; Gallimore A; Ager A
Methods Mol Biol; 2018; 1845():99-118. PubMed ID: 30141010
[TBL] [Abstract][Full Text] [Related]
3. High endothelial venules in cancer: Regulation, function, and therapeutic implication.
Vella G; Hua Y; Bergers G
Cancer Cell; 2023 Mar; 41(3):527-545. PubMed ID: 36827979
[TBL] [Abstract][Full Text] [Related]
4. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
Front Immunol; 2021; 12():690105. PubMed ID: 34054879
[TBL] [Abstract][Full Text] [Related]
5. High endothelial venules (HEVs) in immunity, inflammation and cancer.
Blanchard L; Girard JP
Angiogenesis; 2021 Nov; 24(4):719-753. PubMed ID: 33956259
[TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1
Hua Y; Vella G; Rambow F; Allen E; Antoranz Martinez A; Duhamel M; Takeda A; Jalkanen S; Junius S; Smeets A; Nittner D; Dimmeler S; Hehlgans T; Liston A; Bosisio FM; Floris G; Laoui D; Hollmén M; Lambrechts D; Merchiers P; Marine JC; Schlenner S; Bergers G
Cancer Cell; 2022 Dec; 40(12):1600-1618.e10. PubMed ID: 36423635
[TBL] [Abstract][Full Text] [Related]
7. Understanding high endothelial venules: Lessons for cancer immunology.
Ager A; May MJ
Oncoimmunology; 2015 Jun; 4(6):e1008791. PubMed ID: 26155419
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Cellular Requirements for the Assembly of Tertiary Lymphoid Structures.
Mueller CG; Nayar S; Campos J; Barone F
Adv Exp Med Biol; 2018; 1060():55-72. PubMed ID: 30155622
[TBL] [Abstract][Full Text] [Related]
9. Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival.
Sawada J; Hiraoka N; Qi R; Jiang L; Fournier-Goss AE; Yoshida M; Kawashima H; Komatsu M
Cancer Immunol Res; 2022 Apr; 10(4):468-481. PubMed ID: 35201289
[TBL] [Abstract][Full Text] [Related]
10. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
Trüb M; Zippelius A
Front Immunol; 2021; 12():674565. PubMed ID: 34054861
[TBL] [Abstract][Full Text] [Related]
11. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
[TBL] [Abstract][Full Text] [Related]
12. Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy.
Aoyama S; Nakagawa R; Mulé JJ; Mailloux AW
Front Immunol; 2021; 12():675538. PubMed ID: 34054863
[TBL] [Abstract][Full Text] [Related]
13. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
Tang H; Qiu X; Timmerman C; Fu YX
Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
[TBL] [Abstract][Full Text] [Related]
14. Cellular and Vascular Components of Tertiary Lymphoid Structures.
Mueller CG; Nayar S; Gardner D; Barone F
Methods Mol Biol; 2018; 1845():17-30. PubMed ID: 30141005
[TBL] [Abstract][Full Text] [Related]
15. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.
Rodriguez AB; Peske JD; Woods AN; Leick KM; Mauldin IS; Meneveau MO; Young SJ; Lindsay RS; Melssen MM; Cyranowski S; Parriott G; Conaway MR; Fu YX; Slingluff CL; Engelhard VH
Cell Rep; 2021 Jul; 36(3):109422. PubMed ID: 34289373
[TBL] [Abstract][Full Text] [Related]
16. Role of sulfated O-glycans expressed by high endothelial venule-like vessels in pathogenesis of chronic inflammatory gastrointestinal diseases.
Kobayashi M; Fukuda M; Nakayama J
Biol Pharm Bull; 2009 May; 32(5):774-9. PubMed ID: 19420741
[TBL] [Abstract][Full Text] [Related]
17. Endomucin, a sialomucin expressed in high endothelial venules, supports L-selectin-mediated rolling.
Kanda H; Tanaka T; Matsumoto M; Umemoto E; Ebisuno Y; Kinoshita M; Noda M; Kannagi R; Hirata T; Murai T; Fukuda M; Miyasaka M
Int Immunol; 2004 Sep; 16(9):1265-74. PubMed ID: 15249540
[TBL] [Abstract][Full Text] [Related]
18. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis.
Bai Z; Cai L; Umemoto E; Takeda A; Tohya K; Komai Y; Veeraveedu PT; Hata E; Sugiura Y; Kubo A; Suematsu M; Hayasaka H; Okudaira S; Aoki J; Tanaka T; Albers HM; Ovaa H; Miyasaka M
J Immunol; 2013 Mar; 190(5):2036-48. PubMed ID: 23365076
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth.
Menzel L; Höpken UE; Rehm A
Front Immunol; 2020; 11():591741. PubMed ID: 33343570
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte recruitment via high endothelial venules in lymphoid stroma of Warthin's tumour.
Ohya A; Kobayashi M; Sakai Y; Kawashima H; Kageyama S; Nakayama J
Pathology; 2013 Feb; 45(2):150-4. PubMed ID: 23250041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
